Press Release: Prometheus Research : RogCon and Prometheus Research Enter into Partnership to Support International Natural History Study on SCN2A Mutations

NEW HAVEN, Conn., Jan. 14, 2019 /PRNewswire/ -- RogCon Biosciences, Inc., (RogCon), a biotechnology company leading the discovery and development of novel treatments for patients suffering from SCN2A (Nav1.2) mutations, has partnered with Prometheus Research to support the creation of a...